COSCIENS Biopharma Inc (CSCI)

[Waxman]

The time line is approximately 30 days. Whether it will now be approved is still up in the air. But if the FDA felt Macrilen definitely isn't worthy of consideration this wouldn't be taking place. They wouldn't waste their time. But Macrilen came very close to passing FDA protocols the first time through. And after considering the companies data and the fact that Macrilen does seem to be a much safer test than the Insulin tolerance test. It is very possible it will pass.

The fact is there is a market for this product and it is a safer and easier test to administer. So who knows, especially with the fact that under Trumps new regime they want to ease FDA standards a little. Maybe it will all help to push this through.

That being said even if it does go through its not going to send this to the moon but this company needs to catch a break and start producing and earning and this could be a nice kick start.

I do own stock and I am not trying to pump it in any way, just what my DD tells me. I am very hopeful with what I heard in todays release. Way more than the company peddling its ware's at a few NY conferences this week.

Just my 2 cents